Physiomics plc
(the "Company" or "Physiomics")
Issue of Options
The Company confirms that it has agreed to issue share options to Dr. Mark Chadwick, Chief Executive Officer.
A total of 4,996,125 share options over ordinary shares in the Company ("Share Options") have been granted to Dr. Chadwick under the Enterprise Management Initiative Scheme ("EMI"). The Share Options are exercisable at a price of 0.2933p each.
The Share Options can be exercised within 10 years of the date of grant provided that satisfaction is achieved of certain pre-defined commercial conditions.
At the same time, 4,996,125 share options previously granted to Dr. Chadwick, as set out in the announcement dated 7 February 2011, have been cancelled. All other share options held by Mark Chadwick remain unaffected.
Following this issue, Mark Chadwick continues to hold 28,213,752 share options in accordance with the table below.
|
|
|
|
|
|
Award no. |
Share options granted |
Exercise price p |
Expiry date |
|
|
|
|
|
M Chadwick |
1 |
19,984,500 |
0.270 |
05-Dec-20 |
|
2 |
3,233,127 |
0.340 |
08-Nov-21 |
|
3 |
4,996,125 |
0.2933 |
18-Dec-21 |
Enquiries:
Physiomics plc
Dr Mark Chadwick, CEO
+44 (0)1865 784980
WH Ireland Limited
Katy Mitchell
+44 (0) 161 832 2174